遺伝子編集技術の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3458)
◆英語タイトル:Global Gene Editing Technology Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3458
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:新技術
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、遺伝子編集技術の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(相同組換え、メガヌクレアーゼ)、用途別市場規模(農業、医療、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・遺伝子編集技術の市場動向
・企業の競争状況、市場シェア
・遺伝子編集技術の種類別市場規模(相同組換え、メガヌクレアーゼ)
・遺伝子編集技術の用途別市場規模(農業、医療、その他)
・遺伝子編集技術の北米市場規模2016-2027(アメリカ、カナダ)
・遺伝子編集技術の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・遺伝子編集技術のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・遺伝子編集技術の中南米市場規模2016-2027(メキシコ、ブラジル)
・遺伝子編集技術の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Thermo Fisher Scientific、SIGMA ALDRICH、Dharmacon、Cellectics、CRISPR Therapeutics、AstraZeneca、Bio Rad、Allele Biotech、Recombinetics、Lonza、GE Healthcare、Editas Medicine、Agilent Technologies、QIAGEN NV)
・結論
【レポートの概要】

Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
Gene editing technology refers to the ability for humans to “edit” targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as “molecular scissors,” to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations

In 2021, the global Gene Editing Technology market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Gene Editing Technology status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Gene Editing Technology development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Gene Editing Technology Scope and Market Size
Gene Editing Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Homologous Recombination
Meganuclease

Segment by Application
Agriculture
Medical
Other

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Technology Market Size Growth Rate by Type (2021-2027)
1.2.2 Homologous Recombination
1.2.3 Meganuclease
1.3 Market by Application
1.3.1 Global Gene Editing Technology Market Share by Application (2021-2027)
1.3.2 Agriculture
1.3.3 Medical
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Gene Editing Technology Market Size
2.2 Gene Editing Technology Market Size by Regions
2.2.1 Gene Editing Technology Growth Rate by Regions (2021-2027)
2.2.2 Gene Editing Technology Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Gene Editing Technology Revenue by Players (2020-2021)
3.2 Gene Editing Technology Key Players Headquaters and Area Served
3.3 Key Players Gene Editing Technology Product/Solution/Service
3.4 Date of Enter into Gene Editing Technology Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global Gene Editing Technology Market Size by Type (2021-2027)
4.2 Global Gene Editing Technology Market Size by Application (2021-2027)

5 North America
5.1 North America Gene Editing Technology Market Forecast (2021-2027)
5.2 Gene Editing Technology Key Players in North America
5.3 North America Gene Editing Technology Market Size by Type
5.4 North America Gene Editing Technology Market Size by Application
6.4.4 Canada

6 Europe
6.1 Europe Gene Editing Technology Market Forecast (2021-2027)
6.2 Gene Editing Technology Key Players in Europe
6.3 Europe Gene Editing Technology Market Size by Type
6.4 Europe Gene Editing Technology Market Size by Application

7 Japan
7.1 Japan Gene Editing Technology Market Forecast (2021-2027)
7.2 Gene Editing Technology Key Players in Europe
7.3 Japan Gene Editing Technology Market Size by Type
7.4 Japan Gene Editing Technology Market Size by Application

8 Rest of World
8.1 China
8.1.1 China Gene Editing Technology Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Gene Editing Technology Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Gene Editing Technology Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Details
9.1.2 Thermo Fisher Scientific Description and Business Overview
9.1.3 Thermo Fisher Scientific Gene Editing Technology Introduction
9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Technology Business (2020-2021)
9.1.5 Thermo Fisher Scientific Recent Development
9.2 SIGMA ALDRICH
9.2.1 SIGMA ALDRICH Company Details
9.2.2 SIGMA ALDRICH Description and Business Overview
9.2.3 SIGMA ALDRICH Gene Editing Technology Introduction
9.2.4 SIGMA ALDRICH Revenue in Gene Editing Technology Business (2020-2021)
9.2.5 SIGMA ALDRICH Recent Development
9.3 Dharmacon
9.3.1 Dharmacon Company Details
9.3.2 Dharmacon Description and Business Overview
9.3.3 Dharmacon Gene Editing Technology Introduction
9.3.4 Dharmacon Revenue in Gene Editing Technology Business (2020-2021)
9.3.5 Dharmacon Recent Development
9.4 Cellectics
9.4.1 Cellectics Company Details
9.4.2 Cellectics Description and Business Overview
9.4.3 Cellectics Gene Editing Technology Introduction
9.4.4 Cellectics Revenue in Gene Editing Technology Business (2020-2021)
9.4.5 Cellectics Recent Development
9.5 CRISPR Therapeutics
9.5.1 CRISPR Therapeutics Company Details
9.5.2 CRISPR Therapeutics Description and Business Overview
9.5.3 CRISPR Therapeutics Gene Editing Technology Introduction
9.5.4 CRISPR Therapeutics Revenue in Gene Editing Technology Business (2020-2021)
9.5.5 CRISPR Therapeutics Recent Development
9.6 AstraZeneca
9.6.1 AstraZeneca Company Details
9.6.2 AstraZeneca Description and Business Overview
9.6.3 AstraZeneca Gene Editing Technology Introduction
9.6.4 AstraZeneca Revenue in Gene Editing Technology Business (2020-2021)
9.6.5 AstraZeneca Recent Development
9.7 Bio Rad
9.7.1 Bio Rad Company Details
9.7.2 Bio Rad Description and Business Overview
9.7.3 Bio Rad Gene Editing Technology Introduction
9.7.4 Bio Rad Revenue in Gene Editing Technology Business (2020-2021)
9.7.5 Bio Rad Recent Development
9.8 Allele Biotech
9.8.1 Allele Biotech Company Details
9.8.2 Allele Biotech Description and Business Overview
9.8.3 Allele Biotech Gene Editing Technology Introduction
9.8.4 Allele Biotech Revenue in Gene Editing Technology Business (2020-2021)
9.8.5 Allele Biotech Recent Development
9.9 Recombinetics
9.9.1 Recombinetics Company Details
9.9.2 Recombinetics Description and Business Overview
9.9.3 Recombinetics Gene Editing Technology Introduction
9.9.4 Recombinetics Revenue in Gene Editing Technology Business (2020-2021)
9.9.5 Recombinetics Recent Development
9.10 Lonza
9.10.1 Lonza Company Details
9.10.2 Lonza Description and Business Overview
9.10.3 Lonza Gene Editing Technology Introduction
9.10.4 Lonza Revenue in Gene Editing Technology Business (2020-2021)
9.10.5 Lonza Recent Development
9.11 GE Healthcare
9.11.1 GE Healthcare Company Details
9.11.2 GE Healthcare Description and Business Overview
9.11.3 GE Healthcare Gene Editing Technology Introduction
9.11.4 GE Healthcare Revenue in Gene Editing Technology Business (2020-2021)
9.11.5 GE Healthcare Recent Development
9.12 Editas Medicine
9.12.1 Editas Medicine Company Details
9.12.2 Editas Medicine Description and Business Overview
9.12.3 Editas Medicine Gene Editing Technology Introduction
9.12.4 Editas Medicine Revenue in Gene Editing Technology Business (2020-2021)
9.12.5 Editas Medicine Recent Development
9.13 Agilent Technologies
9.13.1 Agilent Technologies Company Details
9.13.2 Agilent Technologies Description and Business Overview
9.13.3 Agilent Technologies Gene Editing Technology Introduction
9.13.4 Agilent Technologies Revenue in Gene Editing Technology Business (2020-2021)
9.13.5 Agilent Technologies Recent Development
9.14 QIAGEN NV
9.14.1 QIAGEN NV Company Details
9.14.2 QIAGEN NV Description and Business Overview
9.14.3 QIAGEN NV Gene Editing Technology Introduction
9.14.4 QIAGEN NV Revenue in Gene Editing Technology Business (2020-2021)
9.14.5 QIAGEN NV Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 遺伝子編集技術の世界市場規模・現状・予測2021年-2027年(Global Gene Editing Technology Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。